November 10, 2022 News by Patricia Valerio, PhD Retinal Thinning in Eyes Linked to Worse Restless Legs Syndrome in MS Worse disability scores in multiple sclerosis (MS) patientsĀ with restless legs syndrome (RLS) were significantly associated with the thinning of a retinal layer in the eye in a new study.Ā Overall, the study found that people with MS who experience RLS exhibit more severe disability than those…
August 10, 2022 News by Lindsey Shapiro, PhD Retinal Thinning After Optic Neuritis May Help Predict Relapse Recovery After a relapse involving optic neuritis, or inflammation in the nerves connecting the eyes and brain, measurements of retinal thinning may predict the likelihood of full recovery from future relapses in people with multiple sclerosis (MS), a study suggests. The measurement could identify subclinical nerve cell damage that remains…
November 12, 2020 News by Forest Ray PhD Non-invasive Imaging Technique Reveals Ibudilast’s Neuroprotective Effect A non-invasive retina imaging technique known as optical coherence tomography (OCT) provided evidence of the neuroprotective effect of ibudilastĀ (MN-166) ā an oral medication designed to reduce the body’s inflammatory responses āĀ in people with progressive forms of multiple sclerosis (MS). The data also…
August 12, 2020 News by Steve Bryson, PhD Inflammation Drives Nerve Damage in Early MS, Imaging Study Shows Inflammation drives the loss of brain volume and thinning of the eye’s retina in the first five years of aĀ multiple sclerosis (MS) diagnosis, an imaging study demonstrates.Ā The findings support a therapeutic strategy of halting inflammatory activity during this initial period.Ā …
May 14, 2020 News by Marta Figueiredo, PhD Progressive MS Linked to Faster Retinal Atrophy, Study Shows People with progressive forms of multiple sclerosisĀ (MS) have faster and disease-modifying therapy (DMT)-resistant retinal atrophy (thinning), compared to those with relapsing-remitting MS (RRMS), a study shows. Data also highlighted that the thickness of deeper layers of the retina could be used as potential biomarkers of neurodegeneration in…
September 12, 2019 News by Jose Marques Lopes, PhD #ECTRIMS2019 – No Retinal Thinning with Ocrevus in Relapsing MS Patients, Phase 3 Trials Show Treating relapsing multiple sclerosis (MS) patients with Ocrevus (ocrelizumab) is not associated with retinal thinning ā unlike treatment with Rebif (interferon beta-1a), according to two Phase 3 trials. The findings also showed a link between retinal thinning and brain volume loss. The study, ā…